The AAE Steering Committee has defined an overall strategy and clear agenda spanning 2015–2017 "Continuity and Innovation - Towards a more effective response to HIV". Through this, we will strengthen our response to the epidemic, maintain our commitments and provide a framework in which we can prioritise our actions.
It is AAE’s duty to keep HIV/AIDS and co-infections as priorities on EU, national and regional health agendas. AAE will build the advocacy capacity of civil society organisations, in order to mitigate the obstacles that limit universal access to prevention, treatment, care and affordable of medicines.
